Name:
Cenobamate [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl]carbamate
Type:
Anticonvulsant
AKA:
2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)
Cenobamate [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl]carbamate image
Synthetic substance, no natural derivative
IUPAC Logo
Cenobamate [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl]carbamate image
Cenobamate, an anticonvulsant, was developed in the 2010s for the treatment of epilepsy. Its development reflects ongoing research into effective treatments for neurological disorders. Cenobamate's introduction has provided a new option for managing seizures with a focus on efficacy and safety.
Synthetic Substances Image
Cenobamate is a medication used to treat seizures. It has sedative effects and modulates brain activity, acting as a downer. Short-term use helps control seizures, while long-term use is generally safe with monitored dosing. Overdose risks include excessive sedation and respiratory depression. Safe use involves following prescribed dosages and regular medical supervision. Recent research highlights its efficacy in treating refractory seizures and its safety profile.
N/A
Cenobamate is an anticonvulsant used for seizure disorders, improving mood and reducing anxiety. Long-term use is generally well-tolerated, though research is ongoing to understand its full psychological impact and risks.
N/A
Cenobamate is a medication used to treat epilepsy, classifying it as a downer. Short-term use reduces seizure frequency and improves control, while long-term use can lead to cognitive impairment and dependence. Overdose risks include severe sedation and potential respiratory depression. Safe dosages are typically prescribed by medical professionals. Recent research highlights its efficacy in managing epilepsy but notes potential side effects such as sedation and cognitive effects. Physical effects include reduced seizure activity, drowsiness, and potential for respiratory depression.
N/A